Financials
- Market Capitalization 3.82 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1533 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.11 USD | -3.97% | +1.08% | +12.99% | +23.11% | 3.87 B USD | ||
| 1541 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD | ||
| 1557 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.16 USD | -5.02% | -4.63% | -4.06% | +19.24% | 3.75 B USD | ||
| 1563 | RCUS Arcus Biosciences, Inc. Common Stock | 29.19 USD | -4.61% | -4.30% | +6.46% | +176.42% | 3.72 B USD |